# Dexpramipexole Renal PK Study

> **NCT01424176** · PHASE1 · COMPLETED · sponsor: **Knopp Biosciences** · enrollment: 36 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Renal Insufficiency

## Interventions

- **DRUG:** Dexpramipexole (dose 1)
- **DRUG:** Dexpramipexole (dose 2)

## Key facts

- **NCT ID:** NCT01424176
- **Lead sponsor:** Knopp Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424176, "Dexpramipexole Renal PK Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01424176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*